- Filed
- Dec 4, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 15, 2024 | 62.28M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 62.8M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2024 | 62.76M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 64.14M sh |
| Shares Diluted | Q3 2025 · Oct 31, 2023 | 64.41M sh |
| Stock Repurchased | Q3 2025 · Oct 31, 2024 | $58.6M |
| Stock Repurchased | Q3 2025 · Oct 31, 2023 | $99.26M |
| Capex | Q3 2025 · Oct 31, 2024 | $12.17M |
| Capex | Q3 2025 · Oct 31, 2023 | $12.84M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2024 | $98.23M |
| Operating Cash Flow | Q3 2025 · Oct 31, 2023 | $81.68M |
| Long Term Debt | Q3 2025 · Oct 31, 2024 | $412.24M |
| Long Term Debt | Q3 2025 · Jan 31, 2024 | $410.97M |
| Short Term Debt | Q3 2025 · Oct 31, 2024 | $0 |
| Short Term Debt | Q3 2025 · Jan 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Oct 31, 2024 | $182.82M |
| Cash And Equivalents | Q3 2025 · Jan 31, 2024 | $241.4M |
| Cash And Equivalents | Q3 2025 · Oct 31, 2023 | $209.65M |
| Stockholders Equity | Q3 2025 · Oct 31, 2024 | $879.08M |
| Stockholders Equity | Q3 2025 · Jan 31, 2024 | $830.05M |
| Current Liabilities | Q3 2025 · Oct 31, 2024 | $386.98M |
| Current Liabilities | Q3 2025 · Jan 31, 2024 | $418.17M |
| Total Liabilities | Q3 2025 · Oct 31, 2024 | $930.18M |
| Total Liabilities | Q3 2025 · Jan 31, 2024 | $957.44M |
| Current Assets | Q3 2025 · Oct 31, 2024 | $510.29M |
| Current Assets | Q3 2025 · Jan 31, 2024 | $573.17M |
| Total Assets | Q3 2025 · Oct 31, 2024 | $2.25B |
| Total Assets | Q3 2025 · Jan 31, 2024 | $2.23B |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $0.39 |
| Eps Diluted | Q3 2025 · Oct 31, 2024 | $0.58 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | $0.12 |
| Eps Diluted | Q3 2025 · Oct 31, 2023 | −$0.09 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $0.40 |
| Eps Basic | Q3 2025 · Oct 31, 2024 | $0.58 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | $0.12 |
| Eps Basic | Q3 2025 · Oct 31, 2023 | −$0.09 |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $95.99M |
| Sga Expense | Q3 2025 · Oct 31, 2024 | $282.44M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $87.88M |
| Sga Expense | Q3 2025 · Oct 31, 2023 | $297.53M |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $37.74M |
| Rd Expense | Q3 2025 · Oct 31, 2024 | $109.82M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $32.08M |
| Rd Expense | Q3 2025 · Oct 31, 2023 | $97.92M |
| Net Income | Q3 2025 · Oct 31, 2024 | $28.72M |
| Net Income | Q3 2025 · Oct 31, 2024 | $49.49M |
| Net Income | Q3 2025 · Oct 31, 2023 | $12.61M |
| Net Income | Q3 2025 · Oct 31, 2023 | $9.91M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $21.75M |
| Operating Income | Q3 2025 · Oct 31, 2024 | $60.06M |
| Operating Income | Q3 2025 · Oct 31, 2023 | $26.72M |
| Operating Income | Q3 2025 · Oct 31, 2023 | $27.98M |
| Gross Profit | Q3 2025 · Oct 31, 2024 | $158.63M |
| Gross Profit | Q3 2025 · Oct 31, 2024 | $461.57M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $153.01M |
| Gross Profit | Q3 2025 · Oct 31, 2023 | $442.46M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2024 | $65.57M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2024 | $194.07M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $65.54M |
| Cost Of Revenue | Q3 2025 · Oct 31, 2023 | $202.82M |
| Revenue | Q3 2025 · Oct 31, 2024 | $224.19M |
| Revenue | Q3 2025 · Oct 31, 2024 | $655.64M |
| Revenue | Q3 2025 · Oct 31, 2023 | $218.55M |
| Revenue | Q3 2025 · Oct 31, 2023 | $645.28M |